ArticleFrontiers in genetics2022

ERBB2 as a prognostic biomarker correlates with immune infiltrates in papillary thyroid cancer.

Yuchen Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.